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Abstract: Type 2 diabetes mellitus is characterized by insulin resistance and hypersecretion of insulin from the pancreas to compensate
for decreased insulin sensitivity in the peripheral tissues. In later stages of the disease insulin-secreting beta cell degeneration commences
and patients require insulin replacement therapy in order to accomplish proper regulation of their blood glucose. Endoplasmic
reticulum (ER) stress in the beta cells is one of the factors contributing to this detrimental effect. Protein kinase R (PKR) is a cellular
stress kinase activated by ER stress and contributing to degeneration of pancreatic islets. In order to determine whether inhibition of
PKR activation by specific small molecule inhibitors of PKR ameliorates pancreatic insulin secretion capacity, we treated beta cells with
two imidazole/oxindole-derived inhibitors of PKR kinase, imoxin (C16) and 2-aminopurine (2-AP), in the presence of ER stress. Our
results demonstrate that PKR inhibition suppresses tunicamycin-mediated ER stress without altering the insulin production capacity
of the cells. Palmitic acid-mediated suppression of insulin secretion, however, was subdued significantly by PKR inhibitor treatment
through an ER stress-related mechanism. We suggest that PKR inhibitor treatment may be used to increase the insulin secretion capacity
of the pancreas in later stages of diabetes.
Key words: Type 2 diabetes, protein kinase R, ER stress, β cell degeneration

1. Introduction
Type 2 diabetes (T2D) is a chronic disease that affects
millions of people around the world negatively and causes
various micro- and macrovascular complications in the
body (Drong et al., 2012). In recent years, the prevalence of
T2D in developed and developing countries has increased
drastically, making the disease one of the most important
threats to public health (Whiting et al., 2011). Type 2
diabetes is usually characterized by insulin resistance that
develops after 30 years of age, compared to type 1 diabetes
(T1D), which occurs as an autoimmune disease and causes
insulin deficiency generally during early childhood (Cnop
et al., 2005). Insulin-sensitizing drugs that relieve insulin
resistance and reduce its detrimental effects are frequently
used in early stages of the disease (Peters, 2013). Generally,
these conventional drugs exhibit well-documented blood
glucose-lowering actions and are preferred for their
effectiveness in controlling micro- and macrovascular
complications of diabetes. Given the progressive nature of
the disease, conventional insulin-sensitizing drugs remain
effective in controlling blood glucose levels for a while. In
the later stages of the disease, however, gradual cellular
degeneration of insulin-producing cells of the pancreas

commences and the effectiveness of insulin-sensitizing
drugs decreases significantly (Tibaldi, 2007; Tibaldi and
Rakel, 2007). Typically, during these aforementioned
stages insulin secretagogues, the drugs that stimulate
insulin secretion from the pancreatic cells, are utilized
combined with glucose-lowering pharmaceutics.
However, this combination therapy has little to no effect
in preventing the eventual failure of pancreatic insulin
production. In ultimate stages of the disease, pancreatic
insulin production and secretion becomes so insufficient
that clinicians begin so-called insulin replacement therapy,
supporting patients with exogenous insulin hormone
analogues (Peters, 2013). Due to its relative difficulty of
application and the adverse effects on the life quality of
the patients, insulin therapy is used only after pancreatic
insulin production and secretion fail to achieve effective
control of blood glucose levels (Raskin et al., 2005).
The endoplasmic reticulum (ER) is a crucial
organelle that controls synthesis and folding of secreted
proteins, synthesis of lipids, and maintenance of proper
intracellular Ca2+ balance (Hotamisligil 2009). Some
critical observations in the last decade put the ER in the
spotlight of clinical research. These findings suggest a close
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association between metabolic diseases and increased ER
stress in the metabolically important tissues (Özcan et al.,
2004; Hotamisligil, 2010). ER stress is usually triggered by
accumulation of unfolded protein load in the ER lumen,
which compromises the synthesis and secretion activity
of the organelle (Hotamisligil, 2010). In this scenario, the
cell initiates a relief mechanism called unfolded protein
response (UPR), leading to the halting of global protein
synthesis, increasing the chaperone machinery and thus
the folding capacity of the ER, and lastly clearance of the
unfolded proteins from the ER lumen (Hotamisligil, 2009,
2010). UPR achieves these through at least three sensory/
signal transduction pathways, namely phosphorylation
of eukaryotic initiation factor 2 alpha subunit (eIF2α) by
ER membrane kinase PKR-like endoplasmic reticulum
kinase (PERK), cellular modification of x-box binding
protein-1 (XBP-1) mRNA through inositol-requiring
enzyme 1 (IRE1) protein, and nuclear localization of
ER membrane bound transcription factor activating
transcription factor 6 (ATF6) (Marciniak and Ron, 2006).
Nevertheless, in some cases the ER protein load cannot be
cleared efficiently by UPR pathways or ER stress persists
in a chronic fashion, as in obesity and related metabolic
disorders. In such instances, UPR, through activation of
the C/EBP homologous protein (CHOP) transcription
factor, leads to programmed cell death and disposal of the
troubled cells (Lakshmanan et al., 2013). Recent studies
indicated that this chronic ER stress may be involved in the
β cell degeneration during the late phases of diabetes and
the gradual decrease of insulin secretion capacity of the
pancreas (Engin et al., 2014). Pancreatic beta cell survival
and insulin secretion activity are highly susceptible to
glucolipotoxicity. ER stress can be consistently induced by
free fatty acid palmitate (PA) in the presence of excessive
concentrations of glucose, which in turn induces beta cell
apoptosis and islet degeneration (Barlow et al., 2016; Liu
et al., 2019).
Protein kinase R (PKR) is one of the cytoplasmic
regulators of protein synthesis machinery. Like PERK,
PKR catalyzes phosphorylation of eIF2α in response to
various cellular stress signals. The canonical activator of
PKR is double-stranded RNA, as a defense mechanism
against pathogens such as RNA viruses (Rothenburg et
al., 2009; Carpentier et al., 2016). However, PKR is also
activated by other factors such as heat shock proteins,
growth factors (platelet-derived growth factor, etc.),
heparin and cytokines, reactive oxygen species, and ER
stress-inducers like tunicamycin and thapsigargin (Gil and
Esteban, 2000; Garcia et al., 2007; Watanabe et al., 2018).
The triggering of ER stress by tunicamycin, which inhibits
N-linked glycosylation in the ER, is well documented in
insulin-secreting cells (Srinivasan et al., 2005). In this
context, the main function of PKR is to contribute to
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the blocking of protein translation and hence relieve the
unfolded protein load of ER by phosphorylation of the
eukaryotic initiation factor eIF2α subunit. Nevertheless,
substantial increase of PKR phosphorylation activity is
also involved in insulin resistance and contributes to the
progress of T2D (Nakamura et al., 2010, 2014). Recent
studies have shown that activation of PKR disrupts insulin
signaling (Udumula et al., 2017) and stimulates insulin
resistance in peripheral tissues (Nakamura et al., 2014).
The aim of this study is to determine the effect of
ER stress through PKR activation on insulin secretion
machinery using insulin-producing pancreatic beta cells
(Beta-TC-6) as a model system. Glucose-stimulated insulin
secretion is reported to be impaired by saturated fatty acids
(e.g., PA) by a mechanism involving ER stress activation
in pancreatic islet cells (Kharroubi et al., 2004). The effect
of ER stress on the survival of beta cells is determined by
two different approaches to induce ER stress, namely by
tunicamycin induction and palmitic acid. Finally, the role
of PKR activation in insulin production and secretion is
determined by using specific inhibitors of PKR kinase
activity, the imidazole-oxindole-derived PKR inhibitor
C16 (imoxin) and 2-aminopurine (2-AP) (Ingrand et al.,
2007) on beta cells undergoing ER stress.
2. Materials and methods
2.1. Cell culture and experimental protocol
Mouse Beta-TC-6 (CRL-11506) cells were obtained from
the ATCC and grown in DMEM (GIBCO, Sigma-Aldrich
Cat. No: D-5546) medium supplemented with 10%
fetal bovine serum (GIBCO Cat. No: CP-16-1265), 1%
penicillin/streptomycin (Sigma-Aldrich Cat. No: P-4333),
and 1% L-glutamine (Sigma-Aldrich Cat. No: G-7513).
Cells were incubated in a cell CO2 incubator (NUAIRE)
at 37 °C. Stock solutions of PKR inhibitors imoxin (C16)
(1 mM, Sigma-Aldrich Cat. No: I9785), 2-aminopurine
(250 mM, Sigma-Aldrich Cat. No: A3509), and ER stressinducer tunicamycin (1 mg/mL, Sigma-Aldrich Cat. No:
T7765) were prepared in DMSO (Millipore). Palmitate
(sodium salt, Sigma Cat. No: P9767) was solubilized in
90% ethanol (40 mM), heated to 60 °C, and used in a 1:100
dilution in culture medium as previously described (Guo
et al., 2007). Cells were first treated with PKR inhibitors,
namely imoxin (1 μM) and 2-AP (10 mM) (Nakamura et
al., 2014), for 24 h in normal glucose medium (5.5 mM
D-glucose). Then tunicamycin was applied for 16 h and
cells were incubated in glucose-free medium for 2–3 h.
Finally, the cells were taken from glucose-free medium
and kept in high-glucose medium (33 mM D-glucose) for
8 h and prepared for protein and RNA isolation.
In order to induce ER stress by a more physiologically
relevant regime, we treated the mouse pancreatic cell line
Beta-TC-6 with two different concentrations of palmitate
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(200 and 400 μM) for 24 h in the presence of 33 mM glucose.
We also conducted glucolipotoxicity experiments using
immortalized mouse embryonic fibroblast (MEF) cells
as a control. Percentages of dead cells in MEF and BetaTC-6 after PA treatment were determined by Countess
Automated Cell Counter (Cat. No: C10227) according to
the instructions provided by the manufacturer.
2.2. Protein isolation and western blotting
Following incubation, the cells were lysed with RIPA
buffer (VRM Life Science Cat. No: N653) containing 1%
phosphatase (MedChem Express Cat. No: HY-K0022)
and 1% protease inhibitors (MedChem Express Cat. No:
HY-K0010). Cells in RIPA buffer were freeze-thawed at
20-min intervals three times and centrifuged at 14,000 ×
g. The total protein amount of the cells was determined
by Bradford assay (Abcam Cat. No: ab102532). SDS-PAGE
was performed using proteins loaded equally from each
group as a control. After electrophoresis, protein samples
were transferred to a PVDF membrane by semidry
method. Following transfer, the PVDF membrane was
blocked in 1% (w/v) bovine serum albumin for 1 h.
The blocked membranes were allowed to incubate with
primary antibodies (phospho-elF2α, Elabscience Cat.
No: ENP0093, 1:2000) overnight at 4 °C. The membranes
were then washed and treated with HRP-conjugated
secondary antibodies (antirabbit IgG-HRP, Elabscience
Cat. No: SAEP003, 1:5000) at room temperature for 2 h.
PVDF membrane was imaged on the UV-Chemi Dot2 instrument using ECL solution and anti-β-tubulin
antibody (Elabscience Cat. No: ENT5051, 1:5000) was
used as a loading control. The obtained band images were
analyzed with the software program ImageJ.
2.3. RNA isolation and RT-PCR
Total RNA isolation from cells was performed using
RiboEx Total RNA Isolation Solution” (GeneAll Cat. No:
301-902) and quantified with NanoDrop 8000 (Thermo
Fisher). Complementary DNA was then synthesized
using a reverse transcription PCR kit (WizScript Cat
No: W2211). mRNA was revealed by RT-PCR analysis
with RealAmp SYBR qPCR Master Mix and the
following XBP-1 mRNA primers: spliced XBP-1 forward:
CTGAGTCCGCAGCAGGTG, spliced XBP-1 reverse:
TCCTTCTGGGTAGACCTCTGG, unspliced XBP-1
forward: CAGACTACGTGCACCTCTGC, unspliced
XBP-1 reverse: GGGTCCTTCTGGGTAGACCT, β-actin
forward: AACTGGGACGACATGGAGAA,
reverse:
GAAGGTCTCAAACATGATCTGG. The relative changes
in mRNA expression were achieved by 2–∆∆CT method on
a Thermo Fisher Scientific StepOnePlus Real-Time PCR
instrument.
2.4. ELISA
Insulin levels of cells exposed to different doses of
tunicamycin (8 μg/mL) were determined using the

Elabscience Mouse INS ELISA Kit (Cat. No: E-EL-M2614)
and mouse ultrasensitive ELISA assay (ALPCO Cat#:
08-INSMSU-E01) according to the manufacturer’s
instructions. Calculated insulin levels were expressed as
ng/mL for the Elabscience Mouse INS ELISA Kit or pg/mL
for the mouse ultrasensitive ELISA assay (ALPCO Cat#:
08-INSMSU-E01).
2.5. Statistical analysis
All statistical analysis was performed using Prism 5
for MacOS X software (GraphPad Inc.). Averages from
multiple (at least 3) independent experiments were
compared by two-tailed, unpaired, Student t-tests. P-values
lower than 0.05 were considered statistically significant.
GSIS insulin secretion curves were compared by twoway ANOVA analysis and P-values lower than 0.05 were
considered as significant.
3. Results
3.1. Endoplasmic reticulum stress is suppressed by PKR
inhibitors in pancreatic beta cell line
Tunicamycin increased phosphorylation of the serine
residue of elF2α (Ser-51) compared to the controls, as
expected, which is an indicator of ER stress (Figure 1a). In
order to compare the severity of ER stress induction among
different groups, the intensity of the protein bands of elF2α
Ser-51 phosphorylation was quantified from independent
experiments, normalized by the β-tubulin expression
of the corresponding lanes (Figure 1b). Tunicamycin
triggered significant increase in elF2α phosphorylation in
imoxin and control (DMSO) pretreated cells compared to
their respective controls; however, this increase was not
statistically significant in 2-AP pretreated cells. When
tunicamycin-treated Beta-TC-6 cells were compared to
each other, a significant decrease in elF2α phosphorylation
was observed in imoxin and 2-AP pretreated cells relative
to DMSO pretreated cells (Figure 1b, horizontal lines),
suggesting a mild suppression of ER stress by PKR
inhibitor pretreatment. In order to further determine the
ER stress status in the experimental groups by a second ER
stress indicator, cytoplasmic splicing of XBP-1 mRNA was
determined and quantified by real-time quantitative PCR
using total cDNA from the cells as templates (Figure 1c).
Likewise, tunicamycin induced a marked and significant
increase in the XBP-1 mRNA splicing (normalized to actin
mRNA) in DMSO pretreated cells. Although tunicamycin
caused a similar increase in spliced XBP-1 mRNA in
imoxin and 2-AP pretreated cells, these increases failed to
reach statistical significance. As an indication of the extent
of ER stress induction, fold increases in XBP-1 mRNA
splicing among different tunicamycin-treated cells were
determined (Figure 1d). Here we observed that, although
tunicamycin induction increased the spliced XBP-1
mRNA 35.4-fold in DMSO pretreated cells (compared
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Figure 1. Suppression of ER stress by PKR inhibitors in pancreatic beta cells. a) Western blot analysis of elF2α phosphorylation
(top picture) and β-tubulin (bottom picture) in PKR inhibitor (imoxin and 2-AP) pretreated Beta-TC-6 cells with and without
tunicamycin (Tun) induction. b) Quantification of elF2α phosphorylation (normalized by β-tubulin expression) demonstrated
by bar graph (*P < 0.05, **P < 0.005, NS: not significant). Comparison among tunicamycin-induced groups is indicated by
horizontal lines (#P < 0.05). c) Expression of spliced XBP-1 mRNA in cell lysates (*P < 0.05, NS: not significant) normalized
by actin mRNA expression. d) Fold increase in spliced XBP-1 mRNA expression in tunicamycin-induced Beta-TC-6 cells
compared to their respective controls.

to uninduced controls), this increase was only 2.6- and
3.3-fold in imoxin and 2-AP pretreated cells, respectively.
Overall, we observed a mild but significant suppression
of ER stress in PKR inhibitor pretreated Beta-TC-6 cells
upon tunicamycin induction.
3.2. The effect of PKR inhibition on beta cell insulin biosynthesis activity upon tunicamycin-induced ER stress
In order to determine whether suppression of ER stress by
PKR inhibitors upon tunicamycin induction has any effect
on beta cell insulin biosynthesis capacity, we pretreated
Beta-TC-6 cells 24 h with imoxin, 2-AP, or DMSO,

96

inducd ER stress by 8 μg/mL tunicamycin for 24 h, and
finally prepared cell lysates, which were used to determine
intracellular insulin content by insulin ELISA assay (Figure
2). Assay responsiveness and efficiency were determined
by using a series of dilutions of recombinant insulin as
described by the protocol (Figure 2a). The measured
insulin concentrations in the lysates are indicated as
ng/mL cell lysate (Figure 2b). Moderate decreases in
the intracellular insulin were observed upon 8 μg/mL
tunicamycin induction regardless of the pretreatment,
although the decreases were not statistically significant
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(Figure 2c). Imoxin pretreatment slightly improved in
control cells (uninduced cells); however, the effect was
absent in 2-AP pretreatment (statistically not significant).
3.3. Induction of ER stress in pancreatic beta cells by free
fatty acid toxicity in high-glucose environment
To determine the extent of cell death caused by PA, cells
were suspended after the experiment and analyzed by cell
counter. As expected, PA induced significant cell death
in both cell lines tested (Figures 3a and 3b). In order
to investigate the induction of ER stress in the cells, we
determined Ser-51 phosphorylation of elF2α protein
by western blot (Figures 3c and 3d) and spliced XBP-1
mRNA expression by real-time quantitative PCR (Figures
3e and 3f), using whole cell lysate proteins and cDNAs,
respectively. In both cell lines tested, PA induced ER
stress as evidenced by increased elF2α phosphorylation

and increased spliced XBP-1 mRNA expression in a
dose-dependent manner. Marked increases in elF2α
phosphorylation suggest activation of elF2α kinases PERK
and PKR by PA treatment.
3.4. Impairment of glucose-stimulated insulin secretion
by glucolipotoxicity is subdued by repressing PKR activity
In order to determine the effect of PKR inhibitors imoxin
and 2-PA on PA-derived insulin secretion impairment
in beta cells, we conducted a glucose-stimulated insulin
secretion assay (GSIS) on the Beta-TC-6 cells after PKR
inhibitor pretreatment for 24 h followed by PA treatment.
To be able to determine the newly secreted insulin in the
growth media, samples from the media were collected 0
and 5 min after the cells were switched to high-glucose
medium (33 mM glucose), and the media were replenished

Figure 2. The effect of PKR inhibition on intracellular insulin content. a) Standard curve of known insulin concentration
vs. absorption indication the efficiency of the assay. b) Intracellular insulin concentrations (ng per mL cell lysate) are shown
(pretreatment/tunicamycin concentration 8 μg/mL). c) Bar graph of intracellular insulin concentrations (ng per mL cell
lysate) is shown (pretreatment/tunicamycin concentration).
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Figure 3. Induction of ER stress by PA in high-glucose environment. a) Percentage of dead cells in mouse embryonic fibroblast line
(MEF) after PA treatment. (**P < 0.005). b) Percentage of dead cells in Beta-TC-6 cell line after PA treatment. (**P < 0.005). c) Western
blot analysis of elF2α phosphorylation (top picture) and β-tubulin (bottom picture) in MEF cells by PA. d) Western blot analysis of elF2α
phosphorylation (top picture) and β-tubulin (bottom picture) in Beta-TC-6 cells by PA. e, f) Quantification of elF2α phosphorylation
(normalized by β-tubulin expression) demonstrated by bar graph. g) Expression spliced XBP-1 mRNA in MEF cell lysates after PA
treatment (*P < 0.05) normalized by actin mRNA expression. h) Expression of spliced XBP-1 mRNA in Beta-TC-6 cell lysates after PA
treatment (*P < 0.05, **P < 0.005) normalized by actin mRNA expression.
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with fresh high-glucose media to collect samples at
5-min intervals up to 30 min after the start of the assay
(Figures 4a and 4b). Insulin concentrations in the media,
which were below the detection limit of other assays,
were determined by mouse ultrasensitive ELISA assay
(ALPCO Cat#: 08-INSMSU-E01). Beta-TC-6 cells were
pretreated for 24 h by PKR inhibitors imoxin, 2-AP, and
DMSO before PA treatment. Imoxin and 2-AP are both
imidazole-oxindole-derived molecules. Oxindole, which
does not have any PKR inhibitory activity, was included
as another negative control in the experiment (Ingrand
et al., 2007). Beta-TC-6 cells that were not treated by PA
did not display any impairment or betterment in insulin
secretion efficiency with any pretreatment regime (Figure
4a). Cells that were treated by 400 μM PA in high-glucose
medium (33 mM), on the other hand, displayed various
levels of insulin secretion dependent on the pretreatment
protocol (Figure 4b). Beta-TC-6 cells that were treated
by DMSO and oxindole secreted significantly lower
levels of insulin in the media at 20, 25, and 30 min of the
experiment compared to the cells that were pretreated by
PKR inhibitors imoxin and oxindole (P < 0.05). When the
curves of different pretreatment protocols were compared
by 2-way ANOVA analysis, the insulin secretion curves
of imoxin and 2-AP appeared to be significantly different
from both the DMSO and oxindole pretreatment curves,
indicating that PKR inhibitors suppress insulin secretion
impairment caused by PA treatment of Beta-TC-6 cells
(Figure 4b). Finally, in order to determine the effect of
PKR inhibitor pretreatments on the ER stress levels in
Beta-TC-6 cells, we determined the expression of spliced
and unspliced XBP-1 mRNA in the cell lysates after the
GSIS assay (Figures 4c and 4d). Significant increase in
spliced XBP-1 mRNA was detected in DMSO and oxindole
pretreated cells by 400 μM PA in high-glucose medium
(33 mM) compared to the PKR inhibitor pretreated cells
(P < 0.05). Expression of unspliced XBP-1 mRNA did
not appear to be increased by PA and was not affected
by any pretreatment regime (Figure 4d). In summary, we
demonstrated that PKR inhibitor pretreatment appears
to suppress PA-mediated impairment of insulin secretion
from pancreatic beta cells by suppressing ER stress.
4. Discussion
The discovery of new therapeutics targeting different
molecules has become very crucial in recent years to
overcome the increasing prevalence of metabolic diseases
such as diabetes and obesity. Metabolic inflammation, also
known as metaflammation, is the leading complication
of these diseases. Previously, it has been shown that
inflammatory pathways are triggered and that insulin
signaling is altered by PKR (Nakamura et al., 2010;

Carvalho-Filho et al., 2012), so the suppression of the
PKR pathway may be a novel target of treatment. Here,
we examined the effects of PKR inhibitors on ER stress
markers and insulin secretion in ER-stressed cells. Our
findings suggest that PKR inhibitors are effective in
ameliorating ER stress and improving insulin secretion.
Many lipotoxic and some ER stress inducer-mediated
models have demonstrated that the association of ER
stress with beta cell apoptosis is via the CHOP protein,
one of the downstream targets of IRE1 (Åkerfeldt et al.,
2008; Cunha et al., 2008; Song et al., 2008). However, the
main reason for ER stress-induced cell death in beta cells
is the accumulation of lipids in peripheral tissues (Cunha
et al., 2008). Besides, as we found in our study, it has been
shown that the intermediates of fatty acids degraded by
β-oxidation become much more harmful with high glucose
(Poitout et al., 2010). It will be interesting to see whether
the blocking of PKR activation by small molecules also
protects beta cells from ER stress-mediated apoptosis.
UPR provides phosphorylation of eIF2α to inhibit
general protein translation in order to reduce the damage
caused by protein overload in ER (Youssef et al., 2015).
This process links the PKR and UPR pathways. ER stress
marker expressions have also been shown to increase
significantly in diabetic mice and T2D patients (Laybutt
et al., 2007; Marchetti et al., 2007). Additionally, increased
blood sugar and saturated/unsaturated fatty acids,
especially palmitate, have been found to impair insulin
signaling, cause PERK-mediated phosphorylation of
eIF2α, induce IRE1, and promote UPR in beta cells by
splicing XBP-1 protein (Cnop et al., 2007; Gwiazda et
al., 2009). It was known to us from the published work
that PA induces ER stress in a cultured mouse embryonic
fibroblast cell line. Therefore, we used mouse embryonic
fibroblasts as a positive control for a PA-induced ER
stress model (Guo et al., 2007). In our study, we also
found that eIF2α phosphorylation and XBP splicing
did not occur with high glucose but rather with PA and
glucose coexposed cells. A previous study indicated that
PKR inhibitor imoxin suppresses PKR-mediated eIF2α
phosphorylation and provides a significant increase in
insulin receptor substrate (IRS) expression in vitro. In
the same study, it was found that PKR inhibitors (imoxin
and 2-aminopurine) lower blood glucose and improve the
insulin sensitivity of genetically obese mice (Nakamura et
al., 2014). In our study, imoxin or 2-AP alone did cause a
significant increase in eIF2α phosphorylation and Xbp-1
mRNA splicing in tunicamycin-untreated cells. The reason
for these effects was not determined. However, according
to our observations, PKR inhibition in tunicamycinuntreated cells did not cause any detectable cell death
or visible morphological changes in a way that would
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Figure 4. PA-mediated impairment of insulin secretion is subdued by PKR inhibitors. a) Glucose-stimulated insulin
secretion assay of PA untreated Beta-TC-6 cells (GSIS) pretreated by DMSO, oxindole, imoxin, and 2-AP. Medium
replenished 5 min after switching cells from no-glucose medium to high-glucose medium (33 mM glucose). b) GSIS
assay of PA-treated (400 μM PA) Beta-TC-6 cells pretreated by DMSO, oxindole, imoxin, and 2-AP. Medium replenished
5 min after switching cells from no-glucose medium to high-glucose medium (33 mM glucose). Insulin concentrations of
imoxin and 2-AP pretreated cells compared to oxindole pretreated cells are significantly different at 20, 25, and 30 min (*P
< 0.05). c) Expression of spliced XBP-1 mRNA (sXBP-1) in cell lysates from corresponding cells (*P < 0.05) normalized
by actin mRNA expression. d) Expression of unspliced XBP-1 mRNA (uXBP-1) in cell lysates from corresponding cells
normalized by actin mRNA expression. PA and glucose concentrations of the treatment steps (a, b, c and d) are shown
below.

change the conclusions of our findings. In this study we
demonstrated that PKR inhibition may have additional
benefits against metabolic malformations in diabetic
patients through improving pancreatic insulin secretion
capacity. Our findings suggest that PKR inhibitors may
be used in the treatment of type 2 diabetes mellitus in
later stages in order to ameliorate pancreatic beta cell
degeneration.
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